GSK3685032 TFA
| CAS No. | GSK3685032TFA | Cat. No. | BCP45843 |
| Name | GSK3685032 TFA | ||
| Synonyms | GSK 3685032 TFA; GSK-3685032 TFA; | ||
| Formula | C24H25F3N6O3S | M. Wt | 534.56 |
| Description | GSK3685032 is a first-in-class potent, non-nucleoside, reversible, DNMT1-selective inhibitor (IC50: 0.17 µM), exerting robust DNA hypomethylation and gene activation, potently inhibiting growth of cancer cell lines, displaying improved tolerability and greater DNA hypomethylation than decitabine (DAC), translating into superior antitumour activity in models of AML. | ||
| Related Products | 2170137-61-6（GSK 3685032） 2170140-50-6（(R)-GSK-3685032） | ||
| Pathways | Epigenetics | ||
| Targets | DNA Methyltransferase | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.